SBIR/STTR Research Award

Computer based Screening for Diabetic Retinopathy

Award identifier 2c93c2151851def72870227a38165b43c7aabede4d5734b0228b5a4c2b12bed8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$998,441

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
VisionQuest Biomedical Inc
Proposal award date
2016-09-30
Contract end date
2019-08-31
UEI
GLKJYG8H1HS7
Solicitation number
PAR16-027
Topic code
NEI

Research abstract

Summary VisionQuest Biomedical LLC VisionQuest has developed a diabetic retinopathy DR screening system EyeStar enabled by automated screening software DR RACS that was developed under the EY Phase II SBIR project Our product provides immediate feedback to the physician on the state of diabetic eye disease without burdening an eye care specialist to review those cases without retinal disease Diabetes affects over million Americans and DR is one of its main complications If not detected early DR leads to vision loss and blindness With the number of diabetics projected to grow to over million by worldwide DR has become a serious healthcare concern DR RACS will improve DR screening rates by providing a solution that is low cost and integrated at the point of care and that will result in increased revenues for insurance companies and healthcare providers The main objective of this grant application is to complete the final steps needed to commercialize VisionQuest s EyeStar DR screening system For commercialization VisionQuest requires FDA clearance of the enabling component the DR RACS software This objective will be achieved through two specific aims In Aim we will make VisionQuest and the DR RACS product compliant with the quality system regulations QSR in preparation for regulatory submissions In Aim we will prepare DR RACS for FDA k submission To achieve this goal we will prepare a k pre submission carry out a multi center clinical study and submit a De Novo k application to the FDA At the completion of this project we will have the first FDA cleared automated DR screening software We will then be positioned to commercialize our automatic retinal screening system EyeStar to serve the needs of the healthcare industry in the US and worldwide Narrative Diabetic retinopathy DR is a complication of diabetes a disease that affects over million Americans and is the leading cause of blindness in working age population The main objective of this project is to complete the final steps needed to commercialize VisionQuestandapos s EyeStar DR screening system This project is relevant to public health because it addresses the need of providing better and more widespread eye care to diabetics thus improving their health outcomes and preventing blindness

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

36 SBIR/STTR records share this UEI (2007–2024). Reported award amounts total $28,343,639. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.